Thermo Fisher Scientific TMO
NYSE TMO
$659.18 +10.75 (+1.66%)
As of: Sep 17, 2026 · 3:59 PM EDT

Thermo Fisher Scientific (TMO) Cash from Discontinued Operations (2009 - 2017)

Thermo Fisher Scientific's (TMO) quarterly Cash from Discontinued Operations came in at $1.0 million in Q4 2017, little changed on a YoY basis from $1.0 million in Q4 2016, and up 200.0% quarter-over-quarter from -$1.0 million in Q3 2017.

Analysis

Thermo Fisher Scientific (TMO) Cash from Discontinued Operations (2009 - 2017) Analysis & Trends

Thermo Fisher Scientific (TMO) has reported Cash from Discontinued Operations for 9 consecutive years, with $1.0 million the latest figure, recorded in Q4 2017.

  • For the quarter ending Q4 2017, Cash from Discontinued Operations changed 0.0% year-over-year to $1.0 million; the trailing twelve-month figure through Sep 2018 stood at $1.0 million (up 200.0% YoY), and the FY2017 full-year result was -$1.0 million, up 50.0% from the prior year.
  • Cash from Discontinued Operations advanced to $1.0 million in Q4 2017 per TMO's latest filing, from -$1.0 million in the prior quarter.
  • Across five years, Cash from Discontinued Operations topped out at $1.0 million in Q4 2016 and bottomed at -$3.7 million in Q3 2015.
  • Historically, Cash from Discontinued Operations has averaged -$1.1 million across 5 years, with a median of -$1.0 million in 2014.
  • The sharpest annual moves came in 2015 and 2016: Cash from Discontinued Operations plunged 144.44% in 2015, then soared 200.0% in 2016.
  • Over 5 years, Cash from Discontinued Operations stood at -$1.6 million in 2013, then soared by 50.0% to -$800000.0 in 2014, then slipped by 25.0% to -$1.0 million in 2015, then jumped by 200.0% to $1.0 million in 2016, then changed by 0.0% to $1.0 million in 2017.
  • According to Business Quant data, Cash from Discontinued Operations over the past three periods registered $1.0 million, -$1.0 million, and -$1.0 million for Q4 2017, Q3 2017, and Q2 2017 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn -
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn -
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn -
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn -
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn -
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn -
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn -
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn -
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn -
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 1.00 Mn
Sep 30, 2017 -1.00 Mn
Apr 1, 2017 -1.00 Mn
Dec 31, 2016 1.00 Mn
Oct 1, 2016 -1.10 Mn
Jul 2, 2016 -400,000.00
Apr 2, 2016 -1.50 Mn
Dec 31, 2015 -1.00 Mn
Sep 26, 2015 -3.70 Mn
Jun 27, 2015 -2.20 Mn
Mar 28, 2015 -2.10 Mn
Dec 31, 2014 -800,000.00
Sep 27, 2014 -1.60 Mn
Jun 28, 2014 -900,000.00
Mar 29, 2014 -1.00 Mn
Dec 31, 2013 -1.60 Mn
Sep 28, 2013 -1.60 Mn
Jun 29, 2013 -900,000.00
Mar 30, 2013 -800,000.00
Dec 31, 2012 -7.20 Mn